1. Introduction
===============

Although dietary phosphate (PO~4~) is often viewed in the context of its role in bone growth and development, it is also critically important to muscle growth. Postnatal muscle growth has been characterized as a hypertrophic event because fiber numbers are determined during prenatal life and become fixed around the time of birth. However, muscle fibers display a substantial postnatal increase in DNA content, such that between 50--99% of their total DNA is acquired after birth, depending on the species and muscle type \[[@B1-nutrients-04-00436]\]. Studies have demonstrated that DNA incorporation precedes the accumulation of muscle protein and that muscle fiber diameter in growing animals is directly related to the total number of myonuclei \[[@B1-nutrients-04-00436],[@B2-nutrients-04-00436],[@B3-nutrients-04-00436],[@B4-nutrients-04-00436],[@B5-nutrients-04-00436],[@B6-nutrients-04-00436]\]. These observations led to the notion that DNA incorporation may be a rate-limiting step for protein accretion and postnatal muscle hypertrophy. Nuclei within muscle fibers are post-mitotic and the postnatal accumulation of DNA is due to the proliferation and fusion of satellite cells to myofibers \[[@B7-nutrients-04-00436],[@B8-nutrients-04-00436]\]. Therefore, the proliferation and progression of satellite cells through their myogenic lineage is the key factor controlling lifetime muscle growth \[[@B2-nutrients-04-00436],[@B9-nutrients-04-00436],[@B10-nutrients-04-00436],[@B11-nutrients-04-00436],[@B12-nutrients-04-00436]\]. We have previously demonstrated that in addition to reducing the growth of both muscle and skeletal tissues, severe neonatal dietary PO~4~ deficiency also reduces *in vivo* proliferation of satellite cells \[[@B13-nutrients-04-00436]\]. Other neonatal nutrition deficiencies have also been shown to reduce satellite cell activity and subsequent muscle growth \[[@B14-nutrients-04-00436],[@B15-nutrients-04-00436],[@B16-nutrients-04-00436],[@B17-nutrients-04-00436]\].

While it is intuitive that particular care should be used to avoid nutrient deficiencies in neonates, there has been a historical lack of attention given to dietary PO~4~. The more common concern in regards to PO~4~ nutrition, in both humans and other animals, is the prevention of excessive levels of dietary PO~4~ causing hyperparathyroidism and, in animal agriculture, environmental concerns relating to excess PO~4~ excretion \[[@B18-nutrients-04-00436],[@B19-nutrients-04-00436]\]. Because neonatal PO~4~ nutrition alters the *in vivo* proliferation of satellite cells \[[@B13-nutrients-04-00436]\], and there is support for the nutritional programming of muscle growth via satellite cell activity \[[@B14-nutrients-04-00436],[@B15-nutrients-04-00436],[@B16-nutrients-04-00436],[@B17-nutrients-04-00436]\], our objective in this study was to determine the impact of moderate neonatal dietary PO~4~ deficiency and excess on growth, endocrine parameters of PO~4~ homeostasis, and satellite cell activity in the neonatal pig. Characterizing the response of satellite cells to dietary PO~4~ could offer insight into redefining dietary PO~4~ requirements, and into approaches for optimizing lean growth.

2. Experimental Section
=======================

2.1. Piglets
------------

All animal protocols were approved by the North Carolina State University Institutional Animal Care and Use Committee. Twenty-one cross-bred piglets (24 ± 6 h old, both male and female\] were weighed and allotted on the basis of sex and body weight (BW) to 1 of 3 groups which received either a PO~4~ deficient (0.7% total P), adequate (0.9% total P), or a PO~4~ supra-adequate (1.2% total P) milk replacer ([Table 1](#nutrients-04-00436-t001){ref-type="table"}). The Ca content of all diets was adequate (1.2% total Ca). Nutrient requirements for this age of pigs were determined based on the composition of sow's milk \[[@B20-nutrients-04-00436]\] and an extrapolation from NRC requirements for older pigs \[[@B21-nutrients-04-00436]\]. All pigs were individually housed in raised cages and fed through a gravity-flow milk delivery system \[[@B22-nutrients-04-00436]\]. All piglets were fed equal quantities five times daily and had their total daily intake restricted in order to match the growth rate of sow-reared pigs. Body weight and feed intake were recorded daily throughout the trial. Blood samples were collected initially and every 6 days by venipuncture of the cranial vena cava, and sera was obtained by centrifugation at 3500× *g* and 4 °C. Sera samples were stored at −20 °C until analysis. At the completion of the study, all pigs were orally given 20 mg bromodeoxyuridine (BrdU)/kg body weight in a small quantity of their milk replacer 12 h before tissue collection. Immediately prior to tissue collection pigs were killed by penetrating captive bolt followed by exsanguination. Muscle tissue from the longissimus dorsi was collected aseptically for the isolation of satellite cells and the thyroid was collected for gene expression analysis. Radial bones with attached ulnae were isolated for physical measurements and for determination of mineral content by ashing \[[@B13-nutrients-04-00436]\].
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###### 

Experimental diet composition on an as fed basis ^1^.

                                                Base Diet ^2,3^
  --------------------------------------------- -----------------
  Whey                                          21.6
  Whey protein concentrate                      5.0
  Edible lard                                   24.3
  Soy protein isolate                           30.0
  Calcium carbonate                             1.2
  Dicalcium phosphate                           1.0
  Calcium chloride                              0.33
  Mineral premix ^4^                            0.8
  Vitamin premix ^5^                            0.8
  Potassium sorbate                             0.5
  Dextrose                                      14.6
  [D]{.smallcaps}, [L]{.smallcaps}-Methionine   0.18

^1^ Composition of the powdered milk replacer that was reconstituted at a rate of 175 g/kg final liquid formula;

^2^ Diet was deficient in PO~4~. Potassium phosphate was supplemented to this base diet at reconstitution to create the PO~4~ adequate and supra-adequate diets;

^3^ Manufactured by Milk Specialties Corporation, Dundee, IL;

^4^ Mineral Premix provides per kg: 271 g calcium, 140 mg phosphate, 610 mg sodium, 18.34 g chloride, 129 mg potassium, 14.6 g magnesium, 26.54 g sulfur, 1.85 g copper, 20 g zinc, 68 mg selenium, 124 mg cobalt, 437 mg iodine, 20.8 g iron, 5.44 g manganese, and 60 g choline;

^5^ Vitamin Premix provides per kg: 9.9 g retinyl acetate, 165 mg cholecalciferol, 36.7 mg α-tocopherol, 5.1 g dimethylpyrimidinol bisulfate, 2.04 g thiamin, 8.38 g riboflavin, 4 g pyridoxine, 44 mg vitamin B~12~, 30 g pantothenic acid, 33.1 g niacin, 2.76 g folic acid, 117 g ascorbic acid, and 66 mg biotin.

2.2. Sera Analysis
------------------

Sera phosphate concentrations were determined by the method of Gomori \[[@B23-nutrients-04-00436]\]. Calcium concentrations were determined by flame absorption spectroscopy following dilution in 0.5% lanthium chloride. Sera PTH concentrations were determined using a commercially available kit (Porcine Intact PTH ELISA kit Immutopics, San Clemente, CA).

2.3. Isolation of Satellite Cells and Determination of *in Vivo* Proliferation
------------------------------------------------------------------------------

Satellite cells isolations were from individual pigs according to a procedure modified from Allen *et al*. \[[@B24-nutrients-04-00436]\], Rhoads *et al*. \[[@B25-nutrients-04-00436]\], and Doumit and Merkel \[[@B26-nutrients-04-00436]\]. This procedure varies from our previously reported isolation procedure \[[@B13-nutrients-04-00436]\], in that isolations were not pre-plated for 2 h on uncoated plates. Only cell isolations that were greater than 90% PAX7 + were utilized. All cultures were incubated at 37 °C in a humidified environment containing 5% CO~2~. The percentage of cells that had incorporated BrdU into their DNA was determined by immunocytochemistry (anti-BrdU, G~3~G~4~; Developmental Studies Hybridoma Bank, University of Iowa) 24 h after cell isolation \[[@B13-nutrients-04-00436]\]. Approximately 200 cells were counted per animal and the percentage proliferation was determined by calculating the ratio of stained cells to total cells. Initial plating densities varied, depending on the number satellite cells isolated from individual animals.

2.4. Cell Culture
-----------------

Cryopreserved satellite cells from individual animals (*n* = 15) from the initial isolation were cultured in proliferation medium (DMEM + 10% FBS + antibiotics) in 15 cm plate, coated with poly-[L]{.smallcaps}-lysine and fibronectin until 60% confluence. Cells were then trypsinized and replated in proliferation medium at 2500 cells/cm^2^. Cells were cultured in proliferative medium for 3 days with complete media changes daily. After 3 days of culture, differentiation medium (DMEM + 2% horse serum + antibiotics) was used for an additional 4 days of culture, with complete media changes daily. *In vitro* cell proliferation was determined at day 1 and day 2 of culture using the Click-iT^®^ EdU Alexa Fluor^®^ 488 HCS Assay (Invitrogen, Carlsbad, CA) according to manufacturer's instructions. Approximately 200 cells were counted per animal and proliferation was measured by calculating the ratio of EdU stained cells to the total number of cells.

Total RNA was isolated and immunofluorescent staining was performed at 3, 5, and 7 days of culture. Cells were fixed in 2% paraformaldehyde and blocked with 1% bovine serum albumin (BSA) and 0.1% triton X-100 in phosphate buffered saline (PBS). The primary antibodies and their dilutions in PBS containing 1% BSA were as follows: (1) mouse monoclonal anti-PAX7 (1:50; AbD Serotec, Raleigh, NC), (2) rabbit polyclonal anti-MYOD1 (1:100; Santa Cruz Biotechnology, Santa Cruz, CA), and (3) mouse monoclonal anti-MYOG (1:50; AbCam, Cambridge, MA). Secondary antibodies (DyLight 488 AffiniPure donkey anti-mouse IgG and Texas Red AffiniPure goat anti-rabbit IgG, Jackson Immunoreasearch, West Grove, PA) were diluted 1:1000 in PBS containing 1% BSA. Nuclei were stained using 4′,6-diamidino-2-phenylindole (DAPI, Sigma, St. Louis, MO).

2.5. Analysis of Gene Expression
--------------------------------

Total RNA was isolated from thyroid tissue using RNeasy Midi Kits (Qiagen, Valencia, CA) and from cultured satellite cells using Ambion RNAqueous Micro Kits (Ambion, Austin, TX) according to manufacturer's instructions. Genomic DNA contamination was removed by treatment with deoxyribonuclease (Ambion DNA free-kit, Austin, TX), and the RNA was then reverse transcribed with Superscript III (Invitrogen Life Technologies, Carlsbad, CA) according to the manufacturer's instructions. The resulting cDNA samples were then treated with RNase H (Invitrogen, Carlsbad, CA) to ensure the removal of residual RNA. Primer sets ([Table 2](#nutrients-04-00436-t002){ref-type="table"}) were designed using software (Integrated DNA Technologies, Coralville, IA) for the examination of parathyroid hormone (*PTH*), calcitonin (*CALCA*), and calcium sensing receptor (*CASR*) gene expression in thyroid tissue; and for *PAX7*, *MYOD1*, and *MYOG* gene expression in cultured satellite cells. Gene expression was normalized to the expression of two control genes, *RPL35* and *RPL4*, in each sample. Thermocycling conditions included 40 cycles of 20 s of melting at 95 °C followed by 20 s of annealing and extension at 60 °C. Following amplification, all samples were subjected to a melt curve analysis. Gene expression in cultured cells was normalized to the adequate group at day 3 for each gene, using a modification of the 2^−Δ∆CT^ method \[[@B27-nutrients-04-00436]\].
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###### 

Primers used for quantification of gene expression by real-time PCR.

  Gene name   Gene ID     Primer sequence
  ----------- ----------- -------------------------------------
  *PAX7*      494466      F: 5′ CAACCACATCCGCCACAAGATAGT 3′
                          R: 5′ AGAGGATCTTGGAGACACAGCCAT 3′
  *MYOD1*     407604      F: 5′ GCGTGCAAACGCAAGACCACTAA 3′
                          R: 5′ AGTCTCGAAGGCCTCGTTGACTTT 3′
  *MYOG*      497618      F: 5′ TGACCCTACAGATGCCCACAATCT 3′
                          R: 5′ GTTGGGCATGGTTTCATCTGGGAA 3′
  *PTH*       399502      F: 5′ ATGCATAACCTGGGCAAACACCTG 3′
                          R: 5′ TAGAAGCTCCGAGGGCAACAAAGT 3′
  *CALCA*     100579174   F: 5′ TCCAGAGCTAAGCGGTFCAGTAAT 3′
                          R: 5′ TTTCTTGCCAGGTGTTTCAGGC 3′
  *CASR*      100520980   F: 5′ CATCAAGTTCCGAAACACGCCCAT 3′
                          R: 5′ GCAGAGCACGAAGCTAATGCCAAA 3′
  *RPL35*     397598      F: 5′ AACCAGACCCAGAAAGAGAAC 3′
                          R: 5′ TTCCGCTGCTGCTTCTTG 3′
  *RPL4*      6124        F: 5′ CAA GAG TAA CTA CAA CCT TC 3′
                          R: 5′ GAA CTC TAC GAT GAA TCT TC 3′

2.6. Statistical Analysis
-------------------------

All data was analyzed using the GLM procedure of SAS (Version 9.2, SAS Institute Inc., Cary, NC). Dietary treatment was considered a fixed effect for growth performance, bone, *in vivo* satellite cell proliferation and thyroid gene expression data, and initial BW was used as a covariate for the growth performance data. For the satellite cell culture data, technical replicates were averaged and dietary treatment and time in culture were considered fixed effects. Differences were considered significant at *P* \< 0.05.

3. Results
==========

Dietary PO~4~ did not have a significant effect on either growth rate or feed intake; however, it did have an effect on feed conversion efficiency (feed intake/BW gain). Pigs that received the supra-adequate PO~4~ diet had improved (*P* \< 0.05) feed conversion efficiency compared to those that received the PO~4~ deficient diet. Although pigs fed the PO~4~ adequate diet did not significantly differ from either the PO~4~ deficient or supra-adequate fed pigs, there was an apparent PO~4~ dose response on feed conversion efficiency ([Table 3](#nutrients-04-00436-t003){ref-type="table"}). Similarly, there appeared to be a PO~4~ dose response on the length and mineral content of the radial bones ([Table 3](#nutrients-04-00436-t003){ref-type="table"}), with a trend (*P* \< 0.06) for longer bones with higher mineral content among the supra-adequate PO~4~ fed pigs compared to the PO~4~ deficient fed pigs. Pigs fed the PO~4~ deficient diet had wider (*P* \< 0.05) radial bones with lower (*P* \< 0.05) dry matter percentage than either the adequate or supra-adequate fed pigs.
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###### 

Effect of dietary PO~4~ on growth parameters sera measurements in growing piglets^1^.

                             PO~4~ Deficient   PO~4~ Adequate     PO~4~ Supra-adequate
  -------------------------- ----------------- ------------------ ----------------------
  BW gain, g/day             191 ± 5           194 ± 4            201 ± 4
  Feed intake, g/day         146 ± 0.7         145 ± 0.6          144 ± 0.6
  Feed Efficiency            0.77 ± 0.02 ^a^   0.75 ± 0.01 ^ab^   0.72 ± 0.01 ^b^
  Sera Ca, mM                                                     
    day 6                    2.91 ± 0.13 ^a^   2.48 ± 0.13 ^b^    2.57 ± 0.13 ^ab^
    day 12                   2.80 ± 0.14       2.71 ± 0.14        2.61 ± 0.14
  Sera PO4, mM                                                    
    day 6                    1.70 ± 0.06 ^b^   1.98 ± 0.06 ^a^    2.05 ± 0.06 ^a^
    day 12                   1.62 ± 0.08 ^b^   2.17 ± 0.08 ^a^    2.26 ± 0.08 ^a^
  Sera PTH, pg/mL                                                 
    day 6                    1.5 ± 2.6 ^b^     13.6 ± 2.6 ^a^     15.9 ± 2.6 ^a^
    day 12                   5.0 ± 15.1 ^b^    37.6 ± 15.1 ^ab^   52.0 ± 15.1 ^a^
  Bone mineral content, g    1.61 ± 0.08       1.72 ± 0.08        1.84 ± 0.08
  Bone Ash %                 32.48 ± 1.02      34.02 ± 1.02       34.16 ± 1.02
  Radial Length, mm          7.12 ± 0.10 ^b^   7.25 ± 0.10 ^ab^   7.42 ± 0.10 ^a^
  Radial Width, mm           0.94 ± 0.03 ^a^   0.81 ± 0.03 ^b^    0.84 ± 0.03 ^b^
  BrdU + Satellite Cell, %   9.9 ± 1.4 ^b^     15.6 ± 1.5 ^a^     17.6 ± 1.7 ^a^

^1^ Both male and female pigs were utilized, PO~4~ deficient and PO~4~ supra-adequate (*n* = 7, 5 males and 2 females) and PO~4~ adequate (*n* = 7, 4 males and 3 females);

^a,b^ Values within a row not sharing a common superscript are different (*P* \< 0.05).

Pigs fed the PO~4~ deficient diet had reduced (*P* \< 0.05) sera PO~4~ and PTH and elevated (*P* \< 0.05) sera Ca levels at day 6 ([Table 3](#nutrients-04-00436-t003){ref-type="table"}). At day 1--2 on study, the effect of the PO~4~ deficient diet on sera PO~4~ remained however, sera Ca levels were no longer significantly different among the treatment groups. Additionally at the completion of the feeding trial, the pigs receiving the PO~4~ deficient diet had approximately 10 fold lower (*P* \< 0.05) sera PTH concentrations than pigs receiving the PO~4~ supra-adequate diet. While the PTH concentrations of the pigs fed the PO~4~ adequate diet were not significantly different from those of pigs fed the other two diets, an apparent dietary PO~4~ dose dependent response in sera PTH concentrations was seen (5.0, 37.6, and 52.0 pg/mL for deficient, adequate, and supra-adequate respectively).

There was reduced (*P* \< 0.05) *in vivo* proliferation of satellite cells isolated from pigs fed the PO~4~ deficient diet compared to all other pigs ([Table 3](#nutrients-04-00436-t003){ref-type="table"}). There was no statistically significant difference in the percentage of BrdU labeled cells isolated from pigs fed the PO~4~ supra-adequate diet when compared to the PO~4~ adequate group. There were no significant differences in the gene expression of PTH in thyroid tissue among the treatment groups. There was greater *CALCA* gene expression in the PO~4~ adequate group compared to both the PO~4~ deficient and the PO~4~ supra-adequate groups (*P* \< 0.05 and *P* \< 0.08, respectively) ([Figure 1](#nutrients-04-00436-f001){ref-type="fig"}). A similar, but not statistically significant (*P* \< 0.06 and *P* \< 0.13, respectively), pattern of gene expression in the thyroid was seen for *CASR*.

![Effect of dietary PO~4~ on the gene expression of (**A**) CASR, and (**B**) calcitonin, in the thyroid of neonatal pigs. Values presented are least square means and standard error of values normalized to cDNA concentrations (*n* = 7). ^a,b^ Values not sharing a common superscript are different (*P* \< 0.05).](nutrients-04-00436-g001){#nutrients-04-00436-f001}

Greater proliferation (*P* \< 0.05) was observed in cells isolated from pigs receiving supra-adequate dietary PO~4~ 1 day after plating relative to cells isolated from pigs in the other treatment groups ([Figure 2](#nutrients-04-00436-f002){ref-type="fig"}). After 2 days of culture in proliferative medium, dietary treatment no longer affected proliferation rate. Gene expression of *PAX7* increased over time but did not differ between treatment groups at any time point. The expression of *MYOD1* mRNA also increased overtime, and the levels at day 7 were approximately 2 fold greater (*P* \< 0.05, [Figure 3](#nutrients-04-00436-f003){ref-type="fig"}B) in cells isolated from PO~4~ deficient pigs compared to those isolated from pigs receiving supra-adequate dietary PO~4~. The *MYOD1* gene expression levels seen in cells isolated from the PO~4~ adequate pigs were intermediate to, and not statistically different from, either of the other treatment groups. A similar pattern was observed in *MYOG* gene expression ([Figure 3](#nutrients-04-00436-f003){ref-type="fig"}C). After 5 days of culture, *MYOG* expression in PO~4~ deficient cells was 3-fold higher (*P* \< 0.05) than PO~4~ adequate cells and tended to be higher than PO~4~ excess cells (*P* = 0.1). After 7 days of culture, *MYOG* expression in satellite cells isolated from PO~4~ deficient pigs was 3-fold higher (*P* \< 0.05) than in cells isolated from either pigs fed the PO~4~ adequate or the supra-adequate diets ([Figure 3](#nutrients-04-00436-f003){ref-type="fig"}C).

Immunofluorescent staining was performed to complement our analysis of changes in gene expression, and is reported as a percentage of positively stained nuclei. After 3 days of culture, satellite cells from both PO~4~ adequate (*P* = 0.14) and PO~4~ supra-adequate (*P* = 0.1) pigs tended to have a higher percentage of PAX7^+^ nuclei ([Figure 3](#nutrients-04-00436-f003){ref-type="fig"}). The percentage of PAX7^+^ cells increased to over 95% in all treatment groups by day 5 of culture, and decreased to less than 4% in all treatment groups by day 7 ([Figure 3](#nutrients-04-00436-f003){ref-type="fig"}). Cells from PO~4~ deficient pigs tended to have a lower percentage of MYOD1^+^ cells relative to PO~4~ adequate (*P* \< 0.13) and PO~4~ supra-adequate (*P* \< 0.1) cells at day 3 of culture ([Figure 3](#nutrients-04-00436-f003){ref-type="fig"}). Although there were no differences in MYOD1 staining among treatment groups at day 5, it should be noted that the percentage of MYOD1^+^ cells increased in cells isolated from PO~4~ deficient pigs while percentages decreased in cells from both PO~4~ adequate and PO~4~ supra-adequate fed pigs. The percentage of MYOD1^+^ cells decreased dramatically in all groups by day 7 of culture. There were no significant differences in MYOG staining among the treatment groups. The percentage of MYOG positive nuclei doubled between day 3 and day 5 of culture and remained elevated at day 7.

![Effect of dietary PO~4~ on *in vitro* satellite cell proliferation. ^a,b^ Values not sharing a common superscript are different (*P* \< 0.05). Values presented are least square means and standard error (*n* = 7).](nutrients-04-00436-g002){#nutrients-04-00436-f002}

![Effect of dietary PO~4~ on the gene expression (top panels) and *in vitro* protein (bottom panels) of myogenic regulatory factors: (**A**, **D**), Pax7, (**B**, **E**) MyoD, and (**C**, **F**) myogenin in satellite cells isolated from neonatal pigs. Values presented are least square means and standard error of values; either percentage of stained nuclei or normalized to cDNA concentrations (*n* = 7). ^a,b^ Values within a timepoint not sharing a common superscript are different (*P* \< 0.05).](nutrients-04-00436-g003){#nutrients-04-00436-f003}

4. Discussion
=============

In this study, we evaluated a range of dietary PO~4~ concentrations fed to neonatal pigs and characterized their response on both a whole animal and cellular level. Since we had previously demonstrated that a severe neonatal PO~4~ deficiency dramatically impacted growth, satellite cell proliferation, and endocrine parameters of PO~4~ status \[[@B13-nutrients-04-00436]\], we wanted to examine a more realistic range of dietary PO~4~ levels to neonatal pigs ranging from a subclinical deficiency to a marginal excess. We achieved a subclinical dietary PO~4~ deficiency among the piglets fed the PO~4~ deficient diet as evident by reduced sera inorganic PO~4~ and PTH, without a reduction in growth rate and only marginal effects on bone growth. We and others have previously demonstrated reduced PTH in response to dietary PO~4~ deficiency, independent of either dietary or circulating levels of Ca \[[@B13-nutrients-04-00436],[@B28-nutrients-04-00436]\]. Despite being of tremendous importance to the homeostatic regulation of both Ca and PO~4~, the interplay between PTH and 1,25-dihydroxycholecalciferol is absent in the neonate. The 1,25-dihydroxycholecalciferol regulatory system is undeveloped or inactive in the neonates \[[@B13-nutrients-04-00436],[@B29-nutrients-04-00436],[@B30-nutrients-04-00436],[@B31-nutrients-04-00436]\]. Therefore, it appears that PTH is the major regulatory hormone of mineral homeostasis in neonates.

Neonatal nutrient deficiencies have been shown to reduce satellite cell number and activity and lead to permanent muscle growth deficits \[[@B14-nutrients-04-00436],[@B32-nutrients-04-00436]\]. While nutrient restriction negatively impacts the activity of satellite cells, the stimulatory effect of nutrition, via insulin signaling and/or AMPK and mTOR signaling, on neonatal muscle growth may also be mediated through satellite cells \[[@B33-nutrients-04-00436],[@B34-nutrients-04-00436]\]. These works provide support for the critical nature of early life nutrition on lifetime growth. While the need to avoid extremes of both dietary PO~4~ deficiency and excess in neonates is intuitive, very little research has been conducted to examine the role of dietary PO~4~ concentrations over the subclinical range in neonates. The potential for lifetime impact on muscle growth via alterations in satellite cell activity coupled with the requirement of dietary PO~4~ for muscle growth and its effect on satellite cell activity *in vivo* \[[@B13-nutrients-04-00436]\], necessitated further examination of the role of dietary PO~4~ on satellite cell activity. Interestingly, despite the subclinical nature of both the dietary PO~4~ deficiency and excess, both diets had a significant impact on satellite cell activity. The subclinical PO~4~ deficiency that was generated in our study resulted in reduced *in vivo* proliferation of satellite cells. As expected, the reduction in the *in vivo* proliferation of satellite cells seen in this study was less dramatic than what was seen previously with a severe PO~4~ deficiency (36.5% *vs.* 70% reduction in proliferation) \[[@B13-nutrients-04-00436]\]. When cultured *in vitro*, the proliferation rate of satellite cells from the PO~4~ deficient pigs did not differ from those of the PO~4~ adequate pigs. Although there was not a significant difference within sampling time point, it is interesting to note that the rate of proliferation of satellite cells from the PO~4~ deficient pigs experienced a dramatic increase on day 2 of culture compared to day 1. This increase in proliferation could be a compensatory response to the greater PO~4~ content of the proliferation medium. A similar increase in the *in vitro* satellite cell proliferation rate of satellite cells obtained from feed-restricted turkey poults has been reported \[[@B16-nutrients-04-00436]\]. Satellite cells isolated from the PO~4~ deficient pigs also had altered gene expression of the myogenic regulatory factors *MYOD1* and *MYOG* as compared to the cells isolated from PO~4~ adequate pigs. The greater gene expression of *MYOD1* and *MYOG* seen among the PO~4~ deficient satellite cells did not correspond to an increase in the percentage of cells that stained positive for the corresponding proteins. In fact, there was actually a trend for reduced MYOD1 staining at day 3 among PO~4~ deficient satellite cells compared to the adequate group. The increases in *MYOD1* and *MYOG* gene expression seen among satellite cells isolated from PO~4~ deficient pigs in this study, do not appear to correspond to greater myogenic differentiation. Based on reduced muscle hypertrophy caused by severe dietary PO~4~ deficiency, it is intriguing to hypothesize that the elevated *MYOD1* and *MYOG* gene expression may be linked to increased apoptotic regulation in these cells. The importance of MYOD1 in regulating the apoptosis of myoblasts via inducing the expression of miR-1 and miR-206 has been demonstrated \[[@B35-nutrients-04-00436],[@B36-nutrients-04-00436]\].

The activity of satellite cells isolated from the pigs receiving the PO~4~ supra-adequate diet were also altered compared with the cells isolated from the PO~4~ adequate pigs. While not statistically significant, there was a numerical increase in the number of proliferating satellite cells *in vivo*. When cultured *in vitro*, the satellite cells isolated from the PO~4~ supra-adequate fed pigs had a significantly greater (*P* \< 0.05) proliferation rate compared to the PO~4~ adequate cells. This, coupled with the numerical increase in the *in vivo* proliferation rate suggests that excess PO~4~ nutrition may increase the proliferative capacity of satellite cells. There were no differences in the gene expression of the myogenic regulatory factors examined or in the staining for these proteins between the cells isolated from the supra-adequate or the adequate PO~4~ fed pigs. Although there was not a statistically significant difference in growth rate among the treatment groups, the supra-adequate PO~4~ fed pigs tended to have greater BW gain than both the deficient and the adequate PO~4~ fed groups (*P* \< 0.10 and *P* \< 0.17, respectively). The slight increase in BW gain coupled with equal feed intake resulted in the pigs fed the PO~4~ supra-adequate diet having an improved feed conversion efficiency when compared to the other treatment groups (*P* \< 0.03 and *P* \< 0.16 for the comparisons with the PO~4~ deficient and the adequate, respectively). When viewed together, the changes seen in satellite cell activity, the tendency for improved growth and improved feed conversion efficiency are suggestive that supra-adequate PO~4~ nutrition increases muscle growth in neonatal pigs.

5. Conclusions
==============

In this study, we have demonstrated that early neonatal PO~4~ nutrition impacts satellite cell activity both *in vivo* and *in vitro*. If the altered *in vitro* activity is truly indicative of a programming event, this could have lifetime consequences for muscle growth and development because the proliferation and myogenic progression of satellite cells is the key factor controlling lifetime muscle growth \[[@B2-nutrients-04-00436],[@B9-nutrients-04-00436],[@B10-nutrients-04-00436],[@B11-nutrients-04-00436],[@B12-nutrients-04-00436]\]. Of particular importance in this study is that alterations in satellite cell activity were seen with a subclinical dietary PO~4~ deficiency. This stresses the importance of understanding how dietary PO~4~ influences developmental programming of muscle tissue, particularly in situations of potentially compromised PO~4~ status (*i.e.*, premature or small for gestational age humans and for low birth-weight piglets). Reductions in lean growth potential could lead to increased risk of obesity in humans and would have substantial economic and environmental consequences for commercial swine production. It is evident that further research is needed to define neonatal nutrient requirements in the context of the potential of nutritional programming of growth.
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